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Abstract
Coenzyme A (CoA) is a ubiquitous and fundamental intracellular cofactor. CoA acts as a carrier of metabolically important
carboxylic acids in the form of CoA thioesters and is an obligatory component of a multitude of catabolic and anabolic
reactions. Acetyl CoA is a CoA thioester derived from catabolism of all major carbon fuels. This metabolite is at a metabolic
crossroads, either being further metabolised as an energy source or used as a building block for biosynthesis of lipids and
cholesterol. In addition, acetyl CoA serves as the acetyl donor in protein acetylation reactions, linking metabolism to protein
post-translational modifications. Recent studies in yeast and cultured mammalian cells have suggested that the intracellular
level of acetyl CoA may play a role in the regulation of cell growth, proliferation and apoptosis, by affecting protein
acetylation reactions. Yet, how the levels of this metabolite change in vivo during the development of a vertebrate is not
known. We measured levels of acetyl CoA, free CoA and total short chain CoA esters during the early embryonic
development of Xenopus laevis using HPLC. Acetyl CoA and total short chain CoA esters start to increase around midblastula
transition (MBT) and continue to increase through stages of gastrulation, neurulation and early organogenesis. Pre-MBT
embryos contain more free CoA relative to acetyl CoA but there is a shift in the ratio of acetyl CoA to CoA after MBT,
suggesting a metabolic transition that results in net accumulation of acetyl CoA. At the whole-embryo level, there is an
apparent correlation between the levels of acetyl CoA and levels of acetylation of a number of proteins including histones
H3 and H2B. This suggests the level of acetyl CoA may be a factor, which determines the degree of acetylation of these
proteins, hence may play a role in the regulation of embryogenesis.
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Introduction
Vast numbers of enzyme-catalysed biochemical transformations
are dependent on cofactors, which are non-protein, chemical
compounds that associate with enzymes and assist their biological
activity. Coenzyme A (CoA) is an essential and ubiquitous cofactor
made from pantothenate (vitamin B5), ATP, and cysteine [1].
CoA acts as a carrier of acyl groups and transports biologically
active carboxylic acids, including small organic acids and fatty
acids, between different enzymatic reactions in the form of CoA
thioesters. CoA thioesters are important intermediates and
precursors in numerous metabolic pathways, including oxidation
of glucose and fatty acids and biosynthesis of lipids. Acetyl CoA is
a CoA thioester which is centrally placed at a junction of multiple
catabolic and anabolic pathways. Mitochondrial acetyl CoA,
derived from catabolism of glucose and beta-oxidation of fatty
acids, can be further oxidised in the citric acid cycle for energy
production, while cytosolic acetyl CoA is a precursor for lipid and
cholesterol biosynthesis. Additionally, both mitochondrial and
nucleocytoplasmic acetyl CoA serve as co-substrates for protein
acetylation reactions, linking cellular metabolism to protein post-
translational modifications.
Cellular levels of CoA and CoA thiosters are not constant and
fluctuate significantly under conditions such as fasting/feeding, in
response to nutrients and hormones and during energetic stress
and cell growth [2–8]. Such changes in CoA metabolites not only
reflect a shift in the metabolic activity of a cell in response to
different intracellular and extracellular stimuli, but can themselves
act as a signal for regulating cellular processes [8–10]. Notably,
recent accumulating evidence suggests that cellular levels of acetyl
CoA can directly influence cell growth, cell cycle, differentiation
and apoptosis by affecting protein acetylation reactions and
epigenetic modifications [8,11–13].
Three forms of protein acetylation have been identified to date:
O-linked, Ne-linked, and Na-linked acetylation. In all three types
of acetylation reactions acetyl CoA donates the acetyl group to the
acceptor protein, releasing free CoA. Ne-linked acetylation of
histones and transcription factors has been recognised for many
years as a post-translation modification important for regulation of
gene transcription [14,15]. It is generally accepted that this type of
acetylation is dynamically regulated by a balance between histone
acetyl transferases (HATs) and histone deacetylases (HDACs),
which themselves are regulated by gene expression and post-
translational modifications, such as phosphorylation and acetyla-
tion [16,17]. However, a number of recent studies have suggested
that the level or availability of acetyl CoA is also an important
factor influencing acetylation reactions [18–20]. In cultured
mammalian cells disruption of ATP citrate lyase (ACL), an
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enzyme that supplies nucleocytoplasmic acetyl CoA, caused a
reduction in histone acetylation and induced differentiation in
mouse C2C12 myoblasts [12,21]. Conversely, reduced expression
of acetyl CoA carboxylase 1 (ACC1), a cytosolic enzyme that
competes with HATs for nucleocytoplasmic acetyl CoA, caused an
increase in bulk histone acetylation [22]. Moreover, a surge in
intracellular acetyl CoA during the oxidative phase of yeast
metabolic cycles induced the Gcn5p/SAGA-catalysed acetylation
of histones at growth genes and acted as a trigger for initiating a
cellular growth programme and cell cycle entry [8,11]. Intracel-
lular acetyl CoA levels have also been implicated in regulation of
Na-linked acetylation and apoptosis. Overexpression of Bcl-xL in
human cells caused a reduction in cellular acetyl CoA and a
concomitant decrease in protein Na-acetylation, which could be
restored by increasing acetyl CoA levels by addition of citrate or
acetate [13]. High levels of acetyl CoA and Na-acetylation were
shown to be associated with increased susceptibility to apoptotic
stimuli [13].
Considering the emerging role of intracellular acetyl CoA levels
in the regulation of cell growth, differentiation, cell cycle, and
apoptosis, we sought to measure changes in the level of this
metabolite in vivo during the embryonic development of a
vertebrate. Most in vivo measurements of CoA species have been
limited to tissues of adult organisms subjected to different
conditions (such as feeding and fasting), whereas how the levels
of CoA species change in a developing organism is largely
unknown. In this study we used embryos of Xenopus laevis, a widely
used model species for studying cellular processes underlying
embryogenesis. We report here that levels of acetyl CoA in vivo
change dramatically during early embryonic development. We
observed that changes in acetyl CoA appear to correlate with
changes in the whole-embryo levels of Ne-acetylation of a number
of proteins, including histones H2B and H3.
Materials and Methods
Ethics Statement
All experiments involving Xenopus laevis were performed under a
Home Office Project Licence in accordance with the Animals
(Scientific Procedures) Act 1986.
Chemicals and antibodies
CoA standards and all common chemicals were from Sigma-
Aldrich. All antibodies were from Cell Signaling Technologies.
The following antibodies were used: acetyl-histone H2A (Lys 5)
(#2576); acetyl-histone H2B (Lys 5) (#2574); acetyl-histone H3
(Lys 9) (#9649); acetyl histone H3 (Lys 18) (#9675); acetyl-histone
H4 (Lys 8) (#2594); acetylated-lysine antibody (#9441); histone
H2A (#2578); histone H2B (#8135); histone H3 (#4499); histone
H4 (#2935).
In vitro fertilisation of Xenopus eggs and sample
collection
In vitro fertilisation was performed as previously described [23].
Fertilised eggs were kept in 0.1X Modified Barth’s Solution (MBS)
until the appropriate stages were reached for collection. Embry-
onic stages were determined according to Nieuwkoop and Faber
[24]. 30 and 20 embryos were collected per stage for HPLC and
Western blotting, respectively. Embryos were transferred to 1.5 ml
tubes and the incubation medium was removed before snap-
freezing in dry ice. Embryos were stored at 280uC until use.
Preparation of samples for HPLC analysis
Frozen embryos (30 embryos per each stage) were partially
thawed on ice and 150 ml of ice cold 5% perchloric acid (PCA) was
immediately added. Samples were homogenised using a pipette,
briefly vortexed and blended with a tissue tearer before
centrifugation at 18,000 g for 5 minutes at 4uC. The supernatant,
which contains CoASH and short-chain CoA esters, was collected
and 1 M triethanolamine was added to a final concentration of
100 mM. The pH was adjusted to pH 6 with 5 M K2CO3 and
potassium perchlorate pellet was removed by centrifugation at
18,000 g for 3 minutes at 4uC. Injection mixture was made by
adding 10 ml of 1.5 M Na2H2PO4, 10 ml of 100 mM Tris-(2-
carboxyethyl) phosphine hydrochloride (TCEP), 5 ml of 100 mM
ethylenediaminetetraacetic acid (EDTA), and 9 ml of methanol to
66 ml of neutralised PCA extract. The injection mixture was
filtered through a 0.2 mm PVDF filter and 50 ml was loaded onto
the HPLC column. For analysis of total short chain CoA esters,
5 M KOH and 100 mM TCEP were added to neutralised PCA
extracts to final concentrations of 0.5 M and 10 mM, respectively.
After incubation at room temperature for 10 minutes, the pH was
adjusted to pH 6 with 2 M HCl and injection mixture was
prepared as above.
HPLC analysis of CoA compounds
This is a modification of a previously published method [25].
The column used was a Kinetex C18 column (100 X 4.60 mm)
with 2.6 mm particle size and 100 A˚ pore size (Phenomenex). The
column temperature was kept at 40uC by a water bath. Solvent A
consisted of 150 mM Na2H2PO4 and 9% methanol and solvent B
consisted of 150 mM Na2H2PO4 and 30% methanol. CoA
compounds were eluted isocratically with solvent A at a flow rate
of 0.8 ml/min for the first 20 minutes after which a linear gradient
to 100% solvent B was applied over 5 min at a flow rate of 0.5 ml/
min. This was followed by a linear gradient back to 100% solvent
A and the flow rate was returned to 0.8 ml/min over 5 minutes.
The column was re-equilibrated with 100% solvent A for 10
minutes before the start of the next run. Elution of CoA
compounds was monitored by absorbance at 254 nm. Peaks for
CoA compounds in Xenopus extracts were identified by comparison
of retention times with those of authentic standards determined on
the same day. The retention time for each compound and day-to-
day variability in retention times are shown in Table S1. The
position of the CoASH and acetyl CoA peaks were also confirmed
using internal standards (Figure S1). The retention times of
CoASH and acetyl CoA peaks were not affected by the PCA
extract (Figure S1). Approximately 90% of the peak areas of
authentic CoASH and acetyl CoA standards added to a Xenopus
PCA extract, in quantities similar to endogenous levels of CoASH
and acetyl CoA, could be recovered (Figure S1, also see Figure S2).
Therefore, CoA compounds in Xenopus extracts were quantified by
comparison of peak areas with those of external standards as this
can give reasonable estimation of true levels of CoASH and acetyl
CoA in Xenopus extracts. Peak area was quantified by Borwin
chromatography software.
Western blotting
Frozen embryos (20 embryos per each stage) were partially
thawed on ice and 80 ml of ice-cold Lysis buffer (50 mM Tris/HCl
pH 7.5, 150 mM NaCl, 50 mM NaF, 5 mM Na4P2O7, 1 mM
EDTA, 10% glycerol, 1% Triton X100 and protease inhibitor
cocktail (Roche)) was added. Samples were homogenised using a
pipette, briefly vortexed and blended with a tissue tearer before
centrifugation at 18,000 g for 10 minutes at 4uC. The supernatant
was carefully transferred, avoiding the fat layer on the surface, to a
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fresh tube and centrifuged again as above for 5 minutes.
Approximately 40 mg of soluble protein in the supernatant was
heated in SDS loading buffer at 99uC for 10 minutes, separated by
SDS-PAGE and transferred to a PVDF membrane (BioRad). The
membrane was blocked with 5% milk powder in Tris-buffered
saline containing 0.1% Tween 20 (TBSt) and incubated overnight
at 4uC with anti-acetyl lysine, anti-acetyl histone or anti-total
histone antibodies diluted (1/1000) in TBSt. Bands were visualised
by enhanced chemiluminescence with HRP-conjugated secondary
antibodies (Promega). The size and intensity of bands were
quantified using MultiGauge software (Fujifilm).
Microinjection
Embryos were dejellied 30–45 min after fertilisation with 2%
cysteine in water and washed with 0.1X MBS. Embryos were
transferred to 0.2X MBS containing 4% Ficoll and 50 mg/ml
gentamycin and injected with one, two or three pulses (approx-
imately 10 nl each) of 1 mM acetyl CoA in water. Control
embryos were injected with water. Injected embryos were allowed
to progress to stage 3 (approximately 3 hours) at 18uC. 10 injected
embryos were combined and collected as above for HPLC or
Western blot analysis.
Statistical analysis
Where appropriate, values are given as means 6 SEM and
statistical significance was calculated using Student’s t test for
unpaired samples. Statistical significance was taken as p,0.05.
Results
Detection of CoA species in Xenopus embryos by HPLC
Using the HPLC conditions described in the Materials and
Methods section, we were able to separate and detect peaks for
commercially obtained standards of CoASH and a number of
CoA thioesters (Figure 1A). The lower limit of detection for
CoASH and acetyl CoA was determined to be 5 pmol (Figure 1B).
HPLC analysis of PCA extracts of Xenopus embryos detected peaks
corresponding to CoASH, succinyl-, HMG/acetoacetyl- and
acetyl-CoA (Figure 1C). The malonyl CoA and HMG/acetoacetyl
CoA peaks were not consistently detectable due to their small size
and/or the presence of other closely eluting peaks. Since our
detection method relies on UV absorption at 254 nm, which
cannot specifically identify CoA compounds, preliminary exper-
iments were performed to check the identity and purity of the CoA
peaks observed in Xenopus PCA extracts. CoA thioesters are readily
hydrolysed into free CoASH and corresponding carboxylic acids
under alkaline conditions. As can be seen in Figure 2A, treatment
of Xenopus PCA extracts with KOH caused disappearance of the
peaks corresponding to succinyl- and acetyl CoA, and an increase
in the peak corresponding to free CoASH, consistent with
hydrolysis of the CoA thioesters into unesterified CoASH. The
identity and purity of CoASH and acetyl CoA peaks were further
verified using citrate synthase and phosphotransacetylase
(Figure 2B). Incubation of a Xenopus extract with citrate synthase,
in the presence of oxaloacetate, caused complete disappearance of
the peak corresponding to acetyl CoA and an increase in the size
of the peak corresponding to CoASH. Conversely, incubation with
phosphotransacetylase, in the presence of acetyl phosphate,
completely removed the peak corresponding to CoASH and
increased the size of the acetyl CoA peak. These results confirm
unequivocally the identity of the CoASH and acetyl CoA peaks
and that there are no other compounds co-eluting with these peaks
that absorb at 254 nm. To ensure our PCA extraction and sample
preparation conditions did not cause degradation of CoA
compounds or conversion of CoA esters to CoASH, we checked
the recovery of known amounts of CoASH and acetyl CoA
standards added at the time of PCA extraction of Xenopus embryos.
Over 90% of added CoASH and acetyl CoA could be recovered
(CoASH, 91%; acetyl CoA, 113% (n = 2)), indicating that the bulk
of CoASH and acetyl CoA originally present in Xenopus embryos
was not lost during the sample preparation procedure. An example
of the recovery experiment is shown in Figure S2.
Levels of acetyl CoA fluctuate during early Xenopus
embryonic development
Cells undergo dramatic biochemical and morphological chang-
es during embryogenesis. In Xenopus, fertilisation of eggs is followed
by a series of synchronous cleavage cycles, characterised by rapid
alterations between S and M phases without gap phases and cell
cycle checkpoints [26]. By the time stage 9 is reached, and the
embryo is at the 4000/cell capacity, an event termed mid-blastula
transition (MBT) takes place. This involves a number of important
changes including loss of synchrony, appearance of gap phases,
initiation of zygotic transcription and cell motility [27]. At MBT,
embryos are largely composed of uncommitted sister cells [28–30].
During gastrulation, cells migrate and form three germ layers (the
ectoderm, mesoderm and endoderm), which later differentiate into
various tissues and organs during organogenesis [31–33]. We have
measured the whole-embryo levels of free CoA, acetyl CoA and
total acid-soluble CoA species, expressed as pmol per embryo, at
different stages (ranging from stage 1 to stage 40) in Xenopus
embryonic development (Figure 3). Measurement of total acid-
soluble CoA species by KOH hydrolysis showed that unesterified
CoASH, succinyl CoA and acetyl CoA are the predominant acid-
soluble CoA species at all the stages analysed (results not shown).
Levels of CoA, acetyl CoA as well as total acid soluble CoA per
embryo remain relatively constant between stages 1–4, however
they start to increase around stages 8–10 and continue to increase
thereafter. Since embryos were grown in 0.1X MBS media in the
absence of exogenous pantothenate or other precursors for CoA,
the observed increase in short chain CoA esters are likely to be due
to increased CoA biosynthesis from precursors stored in the yolk,
decreased CoA degradation and/or increased turnover of long-
chain CoA thioesters. A key finding is that there is a clear shift in
the ratio of acetyl CoA/CoA during the course of early Xenopus
embryonic development. Pre-MBT embryos contain more CoA
than acetyl CoA, however after MBT CoA is overtaken by a more
rapid and dramatic increase in acetyl CoA, which peaks around
stage 21. This shift in the acetyl CoA/CoA ratio takes place during
late gastrulation, neurulation, and early organogenesis, suggesting
these processes may be associated with metabolic remodelling that
results in the accumulation of acetyl CoA, either through increased
production or decreased usage of acetyl CoA. At stage 40, the ratio
of acetyl CoA/CoA returns to a value close to pre-MBT embryos.
This coincides with stages 40/43, when lipid vesicles in cells of
Xenopus embryos disappear and tadpoles start to feed from the
environment [34].
Changes in acetyl CoA during embryonic development
correlate with global protein acetylation
Recent studies in yeast and mammalian cells have suggested
that changes in the intracellular level of acetyl CoA can influence
protein acetylation [18–20]. Therefore, we examined whether
there is any correlation between whole-embryo levels of acetyl
CoA and general Ne-acetylation (simply referred to as acetylation
hereafter) of proteins present in whole-embryo lysates. As shown in
Figure 4, at the whole-embryo level, bulk acetylation of a number
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of proteins, as detected by a general anti-acetyl-lysine antibody,
appears to correlate with changes in acetyl CoA levels, while
acetylation of other proteins are apparently independent of acetyl
CoA levels. Changes in the abundance of acetylated proteins
during embryonic development shown in Figure 4 may reflect
changes in the net rate of acetylation reactions or may simply
reflect stage-specific differences in the abundance of individual
proteins. Therefore, we decided to look at the acetylation state of
specific proteins. The strongest correlation with acetyl CoA levels
was observed for protein bands corresponding to approximately
16–18 KDa (Figure 4). These proteins are likely to be histones,
which are small proteins of 11–22 KDa containing multiple
acetylation sites. Acetylation of histones is developmentally
regulated and plays an important role in the control of gene
expression during embryogenesis [35,36]. We therefore examined
acetylation of core histones, particularly at stages where an
increase in acetyl CoA occurred (stages 8/9–20) (Figure 5). There
is no observable change in acetylation of histone H3 K9 and K18
and histone H2B K5 during stages 1–4, but net acetylation of these
sites start to increase at stage 8/9, followed by a steady increase
until stage 20. The overall pattern is remarkably similar to the
pattern of change in acetyl CoA levels observed at these stages. In
contrast to histones H3 and H2B, total protein content of both
H2A and H4 decreases between stage 4 and stage 8, with little
change in net acetylation of H2A K5 and H4K8.
Microinjection of acetyl CoA into Xenopus embryos
increases protein acetylation
To examine whether an intracellular increase in acetyl CoA can
affect protein acetylation in Xenopus embryos, stage one embryos
were microinjected with appropriate concentrations of acetyl CoA,
so that the resulting increase in acetyl CoA in embryos (up to 3-
fold) was within the range of acetyl CoA levels normally observed
during embryonic development. The microinjected embryos were
Figure 1. Chromatographic separation of CoA standards and a PCA extract of Xenopus embryos. (A) HPLC chromatogram illustrating
separation of CoA compounds. Standards of CoASH, CoA thioesters and adenosine (20–50 pmol each) were separated on a C18 column (Kinetex C18
100 X 4.60 mm column with 2.6 mm particle size and 100 A˚ pore size) using a mobile phase consisting of 150 mM Na2H2PO4 and 9% methanol and a
flow rate of 0.8 ml/min (see Materials and Methods for details). Standards were made up in mobile phase, which additionally contained 5 mM EDTA
and 10 mM TCEP before injection. CoA compounds were detected by absorbance at 254 nm. Retention times (in minutes): malonyl CoA, 3.21;
adenosine, 4.16; CoASH, 5.06; methylmalonyl CoA, 7.26; dephospho CoA, 10.7; succinyl CoA, 11.87; HMG/acetoacetyl CoA, 13.96; acetyl CoA, 14.83.
See Table S1 for day-to-day variability in retention times. (B) Graphs showing linearity between the peak area and the amount of CoASH and acetyl
CoA injected. Different amounts of CoASH and acetyl CoA standards were injected and the peak areas were determined by Borwin chromatography
software. Each data point represents the mean of duplicate measurements. The limit of detection (LOD) for each compound was determined to be
5 pmol (100 nM). (C) Representative chromatogram showing separation of a PCA extract of stage 8/9 Xenopus embryos. CoA peaks were identified by
comparison of retention times with those of authentic standards determined on the same day. Peaks corresponding to CoASH, succinyl CoA, HMG/
acetoacetyl CoA and acetyl CoA were detected. Retention times (in minutes): CoASH, 5.21; succinyl CoA, 12.32; HMG/acetoacetyl CoA, 14.44; acetyl
CoA, 15.43.
doi:10.1371/journal.pone.0097693.g001
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allowed to proceed to stage 3 and protein acetylation was
examined by Western blot (Figure 6). Microinjection of acetyl
CoA dose-dependently increased acetylation of a number of
proteins, including proteins whose acetylation normally increases
at a later stage (bands labelled 3 and 4 in the blot). This result
suggests that a physiological increase in acetyl CoA alone can
increase protein acetylation to some extent. However, for proteins
labelled 3 and 4 in Figure 6, corresponding to the 16–18 KDa
protein bands in Figure 4, even a 3-fold increase in acetyl CoA at
stages 1–3 is not enough to bring about the same level of
acetylation that is observed at stage 9. In fact, these proteins
appear to be heavily acetylated at stage 9, despite the level of
acetyl CoA in stage 9 embryos being only about 50% more than
that in uninjected stage 3 embryos. This may be due to differences
in the expression/activity of the relevant acetyltransferases and/or
histone deacetylases between these stages. We also cannot rule out
the possibility that microinjection of acetyl CoA increased the
expression of these proteins without affecting the net acetylation
rate.
Discussion
In the present study, we have used Xenopus laevis as a model
organism to measure changes in whole-embryo levels of CoA and
acetyl CoA in vivo during vertebrate embryonic development. As
far as we are aware, the only other study that has measured acetyl
CoA levels during the early embryonic development is that by
Vastag et al, who employed a mass spectrometry based approach
to measure changes in 48 common metabolites, including acetyl
CoA, during early Xenopus embryonic development [37]. Based on
their data they concluded that there is no observable change in
acetyl CoA levels between fertilisation and 11 h post-fertilisation
(corresponding to stage 9). This contradicts our data showing a
small but statistically significant increase in acetyl CoA levels
between stage 4 and stage 8/9. The discrepancy may be explained
by the different approaches used by the two studies for sampling
and data analysis. Vastag et al measured metabolites in each of 10–
11 individual embryos, obtained from three different clutches of
eggs, at five different stages between fertilisation and stage 9. Data
from individual embryos were then analysed and presented
separately. This approach was used to identify metabolites whose
Figure 2. Validation of the identity and purity of CoASH and acetyl CoA peaks detected in Xenopus embryo extracts. (A) 30 stage 8/9
embryos were extracted with 150 ml 5% PCA and the PCA soluble fraction was neutralised with TEA/K2CO3. CoA compounds in neutralised PCA
extracts were analysed by HPLC before and after KOH treatment as described in the Materials and Methods section. KOH treatment caused
conversion of peaks corresponding to succinyl CoA and acetyl CoA, to free CoASH. Retention times (in minutes): CoASH, 5.15; succinyl CoA, 12.13;
acetyl CoA, 15.17. (B) 30 stage 8/9 embryos were extracted with 150 ml 5% PCA and the PCA soluble fraction was neutralised with TEA/K2CO3. The
neutralised extract was analysed by HPLC without further treatment (top panel), or after incubation for 10 min at 30uC with 0.11 mM oxaloacetate
(OA) and citrate synthase (CS) (middel panel), or with 60 mM KCl, 9.4 mM acetyl phosphate (AP), and phosphotransacetylase (PTA) (bottom panel).
Incubation of Xenopus extract with citrate synthase, in the presence of oxaloacetate, caused complete disappearance of the peak corresponding to
acetyl CoA and an increase in the size of the peak corresponding to CoASH (peak areas before treatment: CoASH, 9337.25; succinyl CoA, 11626; acetyl
CoA, 6678. Peak areas after treatment: CoASH, 18217.5; succinyl CoA, 11252.25; acetyl CoA, no peak detected). Conversely, incubation with
phosphotransacetylase, in the presence of acetyl phosphate, completely removed the peak corresponding to CoASH and increased the size of the
acetyl CoA peak (peak areas after treatment: CoASH, not detected; succinyl CoA, 9278.5; acetyl CoA, 15213.5). These results confirm unequivocally the
identity of the CoASH and acetyl CoA peaks and that there are no other compounds co-eluting with these peaks that absorb at 254 nm. Retention
times in minutes: top panel; CoASH, 5.17; succinyl CoA, 12.26; acetyl CoA, 15.51; middle panel; CoASH, 5.24; succinyl CoA, 12.43; acetyl CoA, not
detected; bottom panel; CoASH, not detected; succinyl CoA, 12.12; acetyl CoA, 15.36.
doi:10.1371/journal.pone.0097693.g002
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concentrations change robustly and consistently in every embryo.
Their data did not show a consistent increase in acetyl CoA in
every embryo. In our study we pooled 30 embryos for the
measurement of CoA species for each stage and combined data
from multiple different clutches of embryos for statistical analysis.
Our data indicate that statistically, there is a tendency for a small
increase in acetyl CoA between stages 4 and 8/9 when a
population of embryos is considered. However, such an increase
may not be always evident when the level of acetyl CoA in an
individual embryo is measured. The average increase in acetyl
CoA observed during stage 8/9 was only about 40% of the
average level of acetyl CoA during stages 1–4. This may have been
obscured by experimental errors associated with measurement. It
may also be possible there is a slight embryo-to-embryo and/or
clutch-to-clutch variability in the exact timing of the initial
increase in acetyl CoA. Such variability may partly arise from the
fact that different frogs lay eggs with distinct metabolite
concentrations, as observed by Vastag et al [37]. Consistent with
the points discussed above, closer inspection of the data provided
by Vastag et al reveals that in two of the three clutches of embryos
analysed, approximately half of the embryos actually showed an
increase in acetyl CoA levels around 9-11 hours post fertilisation
(corresponding to stages 8-9). It must also be noted that in our
study a more substantial increase in acetyl CoA levels was
observed after stage 9, during stages that were not analysed by
Vastag et al (between stages 9/10–20).
We have found that acetyl CoA levels continue to increase
during stages of gastrulation, neurulation and early organogenesis.
While the blastula is mainly composed of undifferentiated cells,
during and after gastrulation cells gradually start to diversify and
differentiate [28–33]. Therefore, whole-embryo levels of CoA and
acetyl CoA may not necessarily reflect levels of these compounds
in individual cells in an embryo. This may be particularly so after
organogenesis, since measurement in adult organisms has shown
considerable variations in CoA levels in different tissues, likely
reflecting their different metabolic functions [38]. Nevertheless,
our data suggest the emergence of cells (entire population or
subpopulation of cells in embryos) with increasing levels of acetyl
CoA between stages 8/9–13. Recently, a FRET-based probe for
retinoic acid has been developed and successfully used in live
imaging experiments to study concentration gradients of retinoic
acid during embryonic development [39]. Development of such a
probe for acetyl CoA would allow us to identify the distribution of
acetyl CoA in different groups of cells within an embryo during
development.
We have also observed a remarkable similarity between the
patterns of changes in acetyl CoA levels during Xenopus embryonic
development and bulk acetylation levels of a number of proteins,
including histones H3 and H2B, at the whole-embryo level. The
whole-embryo measurement of acetylated proteins and histones
were conducted simply to determine the abundance of the net
products of protein acetylation reactions in an embryo as a whole.
The whole-embryo levels of acetylated proteins and histones
shown in Figures 4 and 5 should not be interpreted as changes in
protein acetylation occurring uniformly in all cells in an embryo.
Histone acetylation is part of a complex mechanism regulating
gene transcription and considerable cell-type specific variations in
histone acetylation profile are observed during embryonic
development [35,36]. The apparent correlation between levels of
acetyl CoA and protein acetylation levels might be purely
Figure 3. Levels of CoASH, acetyl CoA and total short-chain CoA esters during the early embryonic development of Xenopus laevis.
(A) Levels of unesterified CoA (CoASH) and acetyl CoA were measured in neutralised PCA extracts of Xenopus embryos collected at different stages of
early embryonic development. Embryonic stages were determined as described by Nieuwkoop and Faber [24]. 30 embryos were collected for the
determination of CoA compounds at each stage. The number of independent measurements (in brackets) performed for each stage is as follows: S1
(8); S2 (5); S3 (5); S4 (9); S8/9 (6); S9/10 (9); S12.5/13 (4); S20 (6); S21/23 (3); S27/28 (3); S37/38 (4); S40 (3). Each data point represents the mean +/2
SEM. * indicates statistical significance (p,0.05) compared to the immediately preceding stage as determined by Student’s t test. (B) Levels of total
acid-soluble CoA species, representing combined levels of CoASH and total short-chain CoA esters, were determined after KOH hydrolysis as
described in the Materials and Methods section. The number of independent measurements performed for each stage is as follows: S1 (7); S2 (4); S3
(3); S4 (9); S8/9 (6); S9/10 (8); S12.5/13 (4); S20 (6); S21/23 (3); S27/28 (3); S37/38 (4); S40 (3). Each data point represents the mean +/2 SEM. * indicates
statistical significance (p,0.05) compared to the immediately preceding stage as determined by Student’s t test.
doi:10.1371/journal.pone.0097693.g003
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Figure 4. Whole-embryo acetylation levels of a number of proteins in Xenopus embryos appear to correlate with the pattern of
change in acetyl CoA levels. (A) 20 embryos collected at different stages of development were lysed in 80 ml lysis buffer and approximately 40 mg
of soluble protein was separated by SDS-PAGE, transferred to a PVDF membrane and probed with anti-acetyl lysine antibody. Equal protein loading
was checked by Ponceau staining of the membrane and a Coomassie stain of a gel run in parallel. A section of the Ponceau stained membrane is
shown (the complete Ponceau stained membrane and the Coomassie stained gel are shown in Figure S3). Changes in the abundance of a number of
acetylated proteins, including those with molecular weights of approximately 230 KDa, 100 KDa, 16 KDa, and 18 KDa (indicated by arrows), appear to
follow the overall pattern of change in acetyl CoA levels. (B–D, top graphs) Embryos at different stages of development were collected and Western
blotting, with anti-acetyl lysine antibody, was performed as above. The intensity/size of acetylated protein bands at approximately 230 KDa (B),
100 KDa (C) and 16–18 KDa (D) were quantified, normalised to stage 4, and plotted against different stages of development together with levels of
acetyl CoA (taken from Figure 3 and expressed relative to stage 4). Band intensity/size was normalised against stage 4 as this stage is included in all
the blots performed. Each data point represents a single measurement or the mean +/2 SEM of 2–7 measurements. The number of independent
measurements (using samples from independent fertilisations) performed for each stage was as follows: S1 (4); S2 (4); S3 (1); S4 (7); S8/9 (1); S9/10 (7);
S12.5/13 (4); S20 (5); S21 (2); S27/28 (4); S39/39 (2); S40 (3). (B–D, bottom graphs) The means of normalised band intensity/size for acetylated proteins
at approximately 230 KDa (B), 100 KDa (C) and 16–18 KDa (D) were plotted against acetyl CoA levels (taken from Figure 3 and also normalised to
stage 4) and R2 values are shown.
doi:10.1371/journal.pone.0097693.g004
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coincidental, however a number of recent studies suggest that the
level or availability of acetyl CoA is an important determinant for
protein acetylation reactions. In yeast and mammalian cells
disruption of enzymes that supply nucleocytoplasmic acetyl CoA,
ACL and acetyl CoA synthase, is associated with significantly
reduced bulk acetylation of histone [21,40]. Siudeja et al showed
that chemical inhibition of CoA biosynthesis caused an approx-
imate 50% reduction in total CoA in Drosophila cells and a
significant reduction in histone and tubulin acetylation [41]. In
cultured mammalian cells and in mice nutrient starvation caused a
reduction in acetyl CoA and general protein acetylation levels
[42]. Conversely, reduced expression of ACC1, a cytosolic enzyme
that competes with acetyltransferase for nucleocytoplasmic acetyl
CoA, is associated with an increase in bulk histone acetylation in
yeast [22]. Tu and co-workers have provided compelling evidence
that an increase in intracellular acetyl CoA, during the oxidative
phase of the yeast growth cycle, acts as a trigger for initiating
transcription of genes involved in growth and cell cycle entry by
inducing the Gcn5p/SAGA-catalysed acetylation of histones at
growth genes [8,11]. Notably in their study, levels of acetyl CoA
also correlated with global acetylation of histones, including
histone H3 K9 and K18, as detected by Western blotting of total
cell lysates [8].
Figure 5. Whole-embryo acetylation levels of core histones during early Xenopus embryonic development. 20 embryos collected at
different stages of development were lysed in 80 ml lysis buffer and approximately 40 mg of soluble protein was separated by SDS-PAGE, transferred
to PVDF membranes and probed with either site-specific anti-acetyl histone antibodies or total anti-histone antibodies. Total and acetylated histones
were determined on separate membranes. Representative blots are shown. The graphs show means +/2 SEM of normalised band intensity/size
obtained from 3 independent fertilisations. The band intensity/size of total and acetylated histones at each stage is expressed relative to the mean of
all the stages analysed.
doi:10.1371/journal.pone.0097693.g005
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In addition to histones and transcriptional factors, it is now
known that over 1,700 proteins, including many metabolic
enzymes, signalling proteins and other non-DNA binding proteins
are targets of acetylation [43–46]. This suggests protein acetylation
is a post-translational modification as widespread as protein
phosphorylation. Changes in levels of acetyl CoA during
embryonic development can therefore potentially have wide-
ranging downstream effects. It is currently not clear how an
increase in intracellular acetyl CoA can affect cellular processes in
a specific manner. As shown in Figures 4 and 5, a correlation
between the levels of protein acetylation and acetyl CoA was not
observed for all proteins. Although we have observed that
acetylation of some histone sites appear to increase in tune with
acetyl CoA levels after MBT, maternally loaded storage histones
are also known to be acetylated. It is likely that protein acetylation,
and the degree to which changes in acetyl CoA levels may affect
acetylation, still largely depends on the expression/activity of the
relevant HATs and HDACs. Close examination of the available
literature suggests that the origin of acetyl CoA, and/or subcellular
localisation of acetyl CoA, may also confer some level of specificity
to the acetylation reactions and downstream processes that an
increase in acetyl CoA may affect. In mammalian cells ACL was
shown to mediate changes to histone acetylation in response to
glucose [21]. Silencing this enzyme reduced histone acetylation
without affecting acetylation of tubulin or p53, whereas inhibition
of CoA biosynthesis reduced acetylation of both histones and
tubulin [21,41]. Cai et al used chromatin immunoprecipitation
analysis to show that the increase in Gcn5p/SAGA-mediated
histone acetylation, in response to increased acetyl CoA during
oxidative phase in yeast, occurred specifically at genes involved in
growth [8]. In contrast, disruption of ACC1 in the same organism
increased acetylation of histone H3 and H4 in a global untargeted
manner [22]. These observations suggest functional coupling of
different enzymes that supply acetyl CoA and/or coupling of
localised subcellular pools of acetyl CoA with specific HATs and/
or subpopulations of HATs.
Conclusions
In summary, we report the levels of CoA and acetyl CoA during
the early embryonic development of Xenopus laevis. We observe the
levels of acetyl CoA change dramatically during early embryonic
development. Such changes in acetyl CoA may potentially play a
role in embryonic development by affecting protein acetylation.
Future studies should further clarify the causal relationship
between acetyl CoA and protein acetylation and its possible
functional significance during embryonic development.
Supporting Information
Figure S1 Identification of CoASH and acetyl CoA peaks using
internal standards. HPLC chromatograms showing CoASH and
acetyl CoA standards (20 pmol, prepared in water) (a), Xenopus
Figure 6. Microinjection of acetyl CoA to stage one embryo increases protein acetylation levels. Immediately after dejellying (30–45
minutes after fertilisation), stage one embryos were microinjected with increasing amounts of acetyl CoA, as described in the Materials and Methods
section. Control embryos were injected with water. Injected embryos were allowed to progress to stage 3 and collected for HPLC analysis of CoA
compounds or Western blot analysis with anti-acetyl-lysine antibody. For both analyses, 10 injected embryos were used per condition. In addition,
embryos were collected after reaching stage 9. Microinjection of acetyl CoA dose dependently increased acetylation levels of several proteins
(labelled 1–4). Equal protein loading was confirmed by Ponceau staining of the blot. A section of the Ponceau stained membrane is shown (the
complete membrane is shown in Figure S4). For the Western blot shown, linear contrast and brightness adjustment was applied uniformly to the
whole blot for clarity. The intensity/size of each of the bands numbered 1–4 was quantified and expressed relative to control embryos.
doi:10.1371/journal.pone.0097693.g006
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stage 8/9 extract (b), and Xenopus stage 8/9 extract spiked with
20 pmol CoASH and acetyl CoA internal standards before
injection (c). CoASH and acetyl CoA internal standards were
added to the neutralised PCA extract before injection. Retention
times in minutes: (a) CoASH, 5.22; acetyl CoA, 15.70; (b) CoASH,
5.17; acetyl CoA, 15.51; (c) CoASH, 5.22; acetyl CoA, 15.68. Peak
areas: (a) CoASH, 13191.25; acetyl CoA, 13127.75; (b) CoASH,
9337.25; acetyl CoA, 6678; (c) CoASH, 21513.50; acetyl CoA,
18125.50. The retention times of CoASH and acetyl CoA peaks
are not affected by the PCA extract. 92% of CoASH and 87% of
acetyl CoA standards added to the Xenopus PCA extract could be
recovered.
(TIF)
Figure S2 The % recovery of CoASH and acetyl CoA standards
added during PCA extraction of Xenopus embryos. HPLC
chromatograms showing CoASH and acetyl CoA standards
(50 pmol) (a), Xenopus stage 8/9 extract (prepared as described in
Materials and Methods) (b), and Xenopus stage 8/9 extract in which
200 pmol CoA and acetyl CoA standards were added during the
PCA extraction step (c). Retention times in minutes: (a) CoASH,
5.30; acetyl CoA, 15.93; (b) CoASH, 5.29; acetyl CoA, 15.87; (c)
CoASH, 5.22; acetyl CoA, 15.61. Peak areas: (a) CoASH,
33972.25; acetyl CoA, 30919; (b) CoASH, 15006; acetyl CoA,
12468.5; (c) CoASH, 50165.5; acetyl CoA, 48421.75. 91% of
CoASH and 90% of acetyl CoA standards added to Xenopus
embryo sample during PCA extraction could be recovered.
(TIF)
Figure S3 Ponceau stained membrane (A) and Coomassie
stained gel (B) for the blot presented in Figure 4.
(TIF)
Figure S4 Ponceau stained membrane for the blot presented in
Figure 6.
(TIF)
Table S1 Retention times of CoA species for the HPLC analysis.
Retention times determined on randomly selected days, spread
over a period of 12 months, were used to calculate the mean
retention time 6 SEM for each compound. The lowest and the
highest retention times for each compound, observed over the
same time period, are also shown to illustrate the degree of
retention time variability.
(DOCX)
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